LEVORA 0.15/30-28 Drug Patent Profile
Which patents cover Levora 0.15/30-28, and when can generic versions of Levora 0.15/30-28 launch?
Levora 0.15/30-28 is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.
The generic ingredient in LEVORA 0.15/30-28 is ethinyl estradiol; levonorgestrel. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVORA 0.15/30-28?
- What are the global sales for LEVORA 0.15/30-28?
- What is Average Wholesale Price for LEVORA 0.15/30-28?
Summary for LEVORA 0.15/30-28
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 5 |
| Patent Applications: | 692 |
| DailyMed Link: | LEVORA 0.15/30-28 at DailyMed |
Recent Clinical Trials for LEVORA 0.15/30-28
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AbbVie | Phase 1 |
| Intarcia Therapeutics | Phase 1 |
| University of California, Davis | Phase 4 |
US Patents and Regulatory Information for LEVORA 0.15/30-28
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | LEVORA 0.15/30-28 | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 073594-001 | Dec 13, 1993 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

